• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Searching for COVID-19 treatments: First, do no harm.寻找新冠病毒治疗方法：首先，不要造成伤害。
Am J Health Syst Pharm. 2020 Oct 30;77(22):1899-1905. doi: 10.1093/ajhp/zxaa257.
2
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.氯喹、羟氯喹和阿奇霉素用于治疗新型冠状病毒肺炎（SARS-CoV-2感染）时的安全性考量
CMAJ. 2020 Apr 27;192(17):E450-E453. doi: 10.1503/cmaj.200528. Epub 2020 Apr 8.
3
Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.羟氯喹治疗新型冠状病毒肺炎：在等待确凿科学证据期间如何使用
Med Clin (Barc). 2020 Aug 14;155(3):134-135. doi: 10.1016/j.medcli.2020.05.006. Epub 2020 May 16.
4
Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?羟氯喹联合阿奇霉素是否仍将成为 COVID-19 的游戏规则改变者？
Front Immunol. 2020 Aug 7;11:1969. doi: 10.3389/fimmu.2020.01969. eCollection 2020.
5
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.在大流行期间治疗新冠病毒病——超说明书用药、同情用药及随机临床试验
JAMA. 2020 May 19;323(19):1897-1898. doi: 10.1001/jama.2020.4742.
6
Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.COVID-19时代严格的随机对照试验实施
Am J Trop Med Hyg. 2020 Jun;102(6):1154-1155. doi: 10.4269/ajtmh.20-0262.
7
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.氯喹和羟氯喹用于治疗新型冠状病毒肺炎的安全性考量
Clin Microbiol Infect. 2020 Sep;26(9):1276-1277. doi: 10.1016/j.cmi.2020.05.006. Epub 2020 May 16.
8
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.阿奇霉素和羟氯喹对新冠肺炎住院患者的前瞻性预防（ProPAC-COVID）：一项随机对照试验研究方案的结构化总结
Trials. 2020 Jun 10;21(1):513. doi: 10.1186/s13063-020-04409-9.
9
Biggest COVID-19 trial tests repurposed drugs first.规模最大的新冠病毒试验首先测试重新利用的药物。
Nat Biotechnol. 2020 May;38(5):510. doi: 10.1038/s41587-020-0528-x.
10
Covid-19 treatment update: follow the scientific evidence.新冠病毒疾病治疗进展：遵循科学证据。
J Thromb Thrombolysis. 2020 Jul;50(1):43-53. doi: 10.1007/s11239-020-02120-9.

本文引用的文献

1
Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit.评估单独使用羟氯喹或联合使用阿奇霉素在重症监护病房治疗的 2019 年冠状病毒病（COVID-19）感染患者的 QT 间期。
JAMA Cardiol. 2020 Sep 1;5(9):1067-1069. doi: 10.1001/jamacardio.2020.1787.
2
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19).COVID-19 住院患者使用羟氯喹（无论是否联合使用阿奇霉素）导致 QT 间期延长的风险。
JAMA Cardiol. 2020 Sep 1;5(9):1036-1041. doi: 10.1001/jamacardio.2020.1834.
3
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19.羟氯喹在美国 COVID-19 住院患者中的使用效果。
Med. 2020 Dec 18;1(1):114-127.e3. doi: 10.1016/j.medj.2020.06.001. Epub 2020 Jun 5.
4
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.瑞德西韦治疗新冠病毒病-初步报告。回复。
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
5
Association of Azithromycin Use With Cardiovascular Mortality.阿奇霉素使用与心血管死亡率的关联。
JAMA Netw Open. 2020 Jun 1;3(6):e208199. doi: 10.1001/jamanetworkopen.2020.8199.
6
Compassionate Use of Hydroxychloroquine in Clinical Practice for Patients With Mild to Severe COVID-19 in a French University Hospital.羟氯喹在法国某大学附属医院轻至重度 COVID-19 患者中的临床应用
Clin Infect Dis. 2021 Dec 6;73(11):e4064-e4072. doi: 10.1093/cid/ciaa791.
7
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为 COVID-19 暴露后预防的随机试验。
N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.
8
The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.接受羟氯喹和阿奇霉素治疗的新冠肺炎患者的QT间期。
Nat Med. 2020 Jun;26(6):808-809. doi: 10.1038/s41591-020-0888-2.
9
Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States.美国 COVID-19 大流行期间常用药物的处方配药模式。
JAMA. 2020 Jun 23;323(24):2524-2526. doi: 10.1001/jama.2020.9184.
10
Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database.羟氯喹啉和阿奇霉素相关的心血管毒性：世界卫生组织药物警戒数据库分析
Circulation. 2020 Jul 21;142(3):303-305. doi: 10.1161/CIRCULATIONAHA.120.048238. Epub 2020 May 22.

Searching for COVID-19 treatments: First, do no harm.

作者信息

Guharoy Roy, Krenzelok Edward

机构信息

Department of Pharmacy, Baptist Health, Montgomery, AL.

University of Massachusetts Medical School, Worcester, MA.

出版信息

Am J Health Syst Pharm. 2020 Oct 30;77(22):1899-1905. doi: 10.1093/ajhp/zxaa257.

DOI:10.1093/ajhp/zxaa257
PMID:32744592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7454263/
Abstract
摘要